Rhumbline Advisers Has $10.79 Million Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Rhumbline Advisers lessened its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 568,249 shares of the medical instruments supplier’s stock after selling 5,685 shares during the period. Rhumbline Advisers’ holdings in DENTSPLY SIRONA were worth $10,785,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Blue Trust Inc. lifted its holdings in shares of DENTSPLY SIRONA by 15.1% during the third quarter. Blue Trust Inc. now owns 6,492 shares of the medical instruments supplier’s stock worth $162,000 after buying an additional 854 shares during the last quarter. Sequoia Financial Advisors LLC bought a new position in DENTSPLY SIRONA during the third quarter worth $230,000. Allworth Financial LP raised its stake in DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 625 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in DENTSPLY SIRONA by 43.9% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,038 shares of the medical instruments supplier’s stock valued at $326,000 after purchasing an additional 3,671 shares during the period. Finally, State of Alaska Department of Revenue grew its position in DENTSPLY SIRONA by 2.4% in the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after purchasing an additional 560 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $18.75 on Monday. The company’s 50-day moving average price is $18.92 and its two-hundred day moving average price is $21.68. The firm has a market cap of $3.73 billion, a P/E ratio of -9.06, a P/E/G ratio of 1.80 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12 month low of $17.21 and a 12 month high of $34.91.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a yield of 3.41%. DENTSPLY SIRONA’s dividend payout ratio is currently -30.92%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on XRAY. Evercore ISI reaffirmed an “in-line” rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. UBS Group cut their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Tuesday, February 18th. Barrington Research cut their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Finally, Morgan Stanley decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 17th. Ten equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $25.85.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.